Non-nutritive sweeteners may aid sugar reduction without affecting weight or health
The review, led by Eva Marija Čad of the University of Ljubljana and Wageningen University & Research, alongside…
What 720,000 adults reveal about artificial sweeteners and diabetes risk
Data from more than 720,000 adults suggest that long-term consumption of artificial sweeteners may not be metabolically neutral,…
Obesity drugs show early promise against PMOS
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted…
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Tennis legend Serena Williams is speaking openly about her decision to use a GLP-1 weight-loss medication, adding her…
Kroger (KR) Launches GLP 1 Support Program For Weight Management Patients
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
Protein craze can lead to better health if done right
It’s a question that Dr. Travis Wilkes gets asked every day by patients. It is something that Dr.…
Blood ketone threshold may help predict weight loss success
Researchers identify a practical blood ketone threshold linked to greater short-term weight loss, offering new insight into how…
Gray market peptides blur drug and supplement distinctions, raising health risks
As consumers are increasingly using unapproved peptides, short chains of amino acids, hoping to enhance their health, focus,…
Could GLP-1 Drugs Reduce Breast Cancer Risk?
GLP-1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention. As reported by The…
UK pharmacies braced for surge in demand as Wegovy pill now available
Pharmacies in the UK are “bracing themselves” for a surge in patients starting weight loss drugs as the…
Canada approves generic version of Wegovy for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…